Fisher et al. showed that ICAM-1 deficiency or blockade decreased CD8+ T cell infiltration into melanoma (B16-OVA) or colon carcinoma tumors (CT26), respectively, demonstrating ICAM-1 expression affecting T cell infiltration into tumors at least in certain tumor models (125). This evidence concerns the gene ICAM1 and melanoma.